Educational Intervention for Cancer Palliative Care
(EMPOWER 3 Trial)
Trial Summary
What is the purpose of this trial?
Through this award, Michael Hoerger, PhD, MSCR, a psychologist at the Tulane Cancer Center in Louisiana, will lead a study called EMPOWER 3 designed to test an educational intervention to help patients understand palliative care, use it, and feel better emotionally and physically. Participants will be adults with serious cancer diagnoses. Participants will be randomized into two groups. Patients in the control group will get enhanced usual care, meaning standard cancer care and several additional healthcare-related brochures. Patients in the intervention group will get enhanced usual care plus an educational video developed by the investigators and other materials designed to increase understanding and use of palliative care. Family members of patients in the intervention group may also attend if desired. The investigators will track participants' understanding of palliative care, attitudes toward palliative care, symptoms over 6 months of follow-up, and palliative care utilization.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational interventions, so it's likely you can continue your current treatments, but you should confirm with the trial organizers.
What data supports the effectiveness of the treatment Multimedia Psychoeducational Intervention for Palliative Care?
Research shows that psychoeducational interventions, like the EMPOWER 2 Intervention, can improve patients' readiness for palliative care, which is known to enhance quality of life. Additionally, palliative care education is crucial for improving its use, suggesting that educational interventions can help patients better understand and integrate palliative care into their treatment plans.12345
Is the educational intervention for cancer palliative care safe for humans?
What makes the EMPOWER 3 Intervention treatment unique for cancer palliative care?
The EMPOWER 3 Intervention is unique because it uses multimedia psychoeducational tools to help patients understand and integrate palliative care into their cancer management, which can improve their readiness and quality of life. This approach is different from traditional treatments as it focuses on education and empowerment rather than just medical or physical symptom management.128910
Research Team
Michael Hoerger, PhD, MSCR, MBA
Principal Investigator
Tulane University
Eligibility Criteria
This trial is for adults in southeast Louisiana with serious cancer diagnoses, including various advanced stages of lung, hematologic malignancies, melanoma, leukemia, lymphoma, multiple myeloma, breast and genitourinary cancers. They must have been diagnosed or shown progression in the last 90 days and experience severe symptoms like pain or depression.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either enhanced usual care or enhanced usual care plus a multimedia psychoeducational intervention
Follow-up
Participants are monitored for understanding of palliative care, attitudes, symptoms, and utilization over time
Treatment Details
Interventions
- Enhanced Usual Care
- Multimedia Psychoeducational Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
American Cancer Society, Inc.
Collaborator
University Medical Center-New Orleans
Collaborator